期刊文献+

耐甲氧西林金黄色葡萄球菌的研究进展 被引量:25

Progress in methicillin-resistant Staphylococcus aureus
下载PDF
导出
摘要 耐甲氧西林金黄色葡萄球菌(MRSA)已成为医院感染重要的致病菌,MR-SA引起的感染,因其耐药高、死亡率高及经济负担重,成为威胁全球公共卫生安全的严重问题。MRSA多重耐药现象日益严重。了解MRSA的现状,才能更好地及时治疗并且尽可能避免MRSA感染,因此本文对MRSA的流行现状、临床感染、治疗药物、预防传播及经济负担等最新研究现状进行概述。 Methicillin - resistant Staphylococcus aureus ( MRSA ) is the most frequent cause of health care - associated infection, MRSA infection is a threat to patients and the general public worldwide because of the as- sociated morbidity and mortality and high treatment costs. The infection is resistant to common antibiotics. It is important to understand MRSA infec- tion so that it can be treated appropriately and its spread can be preven- ted. The purpose of this review is to provide the progress overview about MRSA : epidemiology,infection, drugs, treatment and prevention.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2011年第4期306-310,共5页 The Chinese Journal of Clinical Pharmacology
关键词 耐甲氧西林金黄色葡萄球菌 流行病学 感染 methicillin - resistant Staphylococcus aureus epidemiology infection
  • 相关文献

参考文献30

  • 1Furuya EY, Lowy FD. Antimicrobial - resistant bacteria in the community setting [ J ]. Nat Rev Microbiol, 2006 ; 4 : 36 - 45.
  • 2Wang L, Barrett JF. Control and prevention of MRSA infections [J]. Methods Mol Biol, 2007; 391:209-225.
  • 3Grundmann H, Aires - de - Sousa M, Boyce J, et al. Emergence and resurgence of meticillin - resistant Staphylococcus aureus as a public - health threat [ J ]. Lancet,2006 ; 368 : 874 - 85.
  • 4汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,李丽,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华,徐元宏,沈继录,单斌,杜艳.2009年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2010,10(5):325-334. 被引量:397
  • 5Kim T, Oh PI, Simor AE. The economic impact of methicillin - resistant Staphylococcus aureus in Canadian hospitals [J]. Infect Control Hosp Epidemiol,2001 ; 22:99 - 104.
  • 6Borg MA, de Kraker M, Scicluna E, et al. Prevalence of methicillin- resistant Staphylococcus aureus (MRSA) in invasive isolates from southern and eastern Mediterranean countries[ J]. J Antimicrob Chemother, 2007 ; 60 : 1310 - 1315.
  • 7Tiemersma EW, Bronzwaer SL, Lyytikainen O, et al. Methicillin - resistant Staphylococcus aureus in Europe, 1999 -2002 [ J ]. Emerg Infect Dis ,2004 ; 10 : 1627 - 1634.
  • 8Gould SW, Cuschieri P, Rollason J, et al. The need for continued monitoring of antibiotic resistance patterns in clinical isolates of Staphylococcus aureus from London and Malta[ J]. Ann Clin Microbiol Antimicrob, 2010; 21:20.
  • 9Herold BC, Immergluck LC, Maranan MC, et al. Community - acquired methicillin -resistant Staphylococcus aureus in children with no identified predisposing risk [ J ]. JAMA, 1998 ; 279 : 593 - 598.
  • 10Vandenesch F , Naimi T, Enright MC, et al. Community - acquired methicinin - resistant Staphylococcus aureus carrying Panton - Valentine leukocidin genes : worldwide emergence[ J]. Emerg Infect Dis ,2003 ; 9 : 978 -984.

二级参考文献16

  • 1Clinical Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing [S]. M100-S19,2009.
  • 2Clinical Laboratory crobial Dilution and Standard Institute Disk Susceptibility Methods for Antimi Testing of Infrequent ly Isolated or Fastidious Bacteria [S]. Approved Guideline M45-A, 2006, 26(19).
  • 3Yang QW, Wang H, Sun HL, et al. Phenotypic and geno typic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China[J]. Antimicrob Agents Chemother,2010, 54(1): 573-577.
  • 4Wang H, Guo P, Sun HL et al. Molecular epidemiology of clinical isolates of carbapenem resistant Acinetobacter spp from chinese hospitals[J]. Antimicrob Agents Chemother, 2007, 51(11): 4022-4028.
  • 5Perez F, Hujer AM, Hujer KM et al. Global challenge of multidrug resistantAcinetobacterbaumannii[J]. Antimicrob Agents Chemother,2007,51(10) : 3471-3484.
  • 6Boucher HW, Talbot G, Bradley JS, et al. Bad bugs, no drugs: No ESKAPE! An update from the IDSA[J]. Clin Infent Dis, 2009, 48(1):1-12.
  • 7Li J, Nation RL, Milne RW, et al. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria [J]. Intl J Antimicrob Agents, 2005, 25(1).-11 25.
  • 8Elemam A, Rahimian J, Mandell W. Infection with panresistant Klebsiella pneumoniae : a report of 2 cases and a brief review of the literature[J]. Clin Infent Dis, 2009,49(2):271-274.
  • 9Pachon Ibanez ME, Jimenez Mejias ME, Pichardo C, et al Activity of tigeeyeline (GAR 936) against Acinetobacter bau mannii strains, including those resistant to imipenem[J] Antimicrob Agents Chemother, 2004,48 ( 11 ):4479-4481.
  • 10Stein GE, Craig WA. Tigecycline: a critical analysis[J]. Clin Infent Dis, 2006, 43(4):518-524.

共引文献396

同被引文献391

引证文献25

二级引证文献177

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部